Related Experiment Video

Updated: Mar 20, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.6K

Raf kinase inhibitor protein1 is a myogenic inhibitor with conserved function in avians and mammals

Gary Coulton1, Yanwen Hou1, Samantha M Mirczuk2

  • 1Institute for Infection and Immunity, St Georges University of London, London, United Kingdom.

Developmental Dynamics : an Official Publication of the American Association of Anatomists
|May 31, 2016
PubMed
Abstract

Insights

Raf Kinase Inhibitor Protein 1 (RKIP) inhibits muscle development in both chick and mouse embryos. Non-phosphorylated RKIP suppresses myogenesis, while its absence promotes muscle cell differentiation.

Area of Science:

  • Muscle development and differentiation
  • Cell signaling pathways
  • Protein phosphorylation and function

Background:

  • Raf Kinase Inhibitor Protein 1 (RKIP) is a known tumor suppressor found in adult tissues.
  • RKIP regulates Raf/Mek/Erk and NFĸB signaling pathways.
  • RKIP's role in muscle, particularly its physiological function, remains largely unknown.

Purpose of the Study:

  • To investigate the expression and function of RKIP in developing muscle.
  • To determine RKIP's role in myogenesis.
  • To elucidate the impact of RKIP phosphorylation on its myogenic inhibitory function.

Main Methods:

  • In situ hybridization and immunofluorescence to detect RKIP expression in embryonic muscle and myoblasts.
  • Manipulation of RKIP levels to assess its effect on myogenesis.
  • Analysis of RKIP phosphorylation state in relation to its function.

Main Results:

  • RKIP is expressed in developing chick embryonic muscle and mouse C2C12 myoblasts.
  • Elevated RKIP levels inhibit myotube differentiation, while reduced RKIP promotes it.
  • The inhibitory effect of RKIP on myogenesis is dependent on its non-phosphorylated state.

Conclusions:

  • RKIP functions as a conserved myogenic inhibitor in both avian and mammalian muscle.
  • The phosphorylation state of RKIP is critical for its role in regulating muscle development.
  • This study clarifies a novel function of RKIP in the context of muscle differentiation.
Keywords:
RKIPmyogenesis

More Related Videos

Assaying Protein Kinase Activity with Radiolabeled ATP08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

19.5K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.0K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K